| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | LYFT | United States | $14.72 | $6,316,261,000.00 | Buy | 29 | 2019 |
#2 | KRG | United States | $24.81 | $844,365,000.00 | Buy | 10 | 2004 |
#3 | TOST | United States | $30.03 | $6,153,000,000.00 | Buy | 22 | 2021 |
#4 | QNST | United States | $14.34 | $282,140,000.00 | Buy | 4 | 2009 |
#5 | AA | United States | $42.40 | $12,831,000,000.00 | Buy | 10 | 2016 |
#6 | RSI | United States | $19.69 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#7 | HL | United States | $17.49 | $645,957,000.00 | Buy | 8 | 2002 |
#8 | IVT | United States | $30.62 | $299,169,000.00 | Buy | 7 | 2005 |
#9 | AMCR | Switzerland | $42.74 | $13,640,000,000.00 | Strong Buy | 8 | 2020 |
#10 | KEY | United States | $20.46 | $7,513,000,000.00 | Buy | 15 | 2005 |
#11 | CDE | United States | $18.51 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#12 | SON | United States | $49.98 | $7,518,753,000.00 | Buy | 9 | 2014 |
#13 | SMG | United States | $50.56 | $3,016,500,000.00 | Buy | 6 | 2012 |
#14 | TREE | United States | $24.18 | $1,117,324,000.00 | Strong Buy | 4 | 2008 |
#15 | GMED | United States | $74.56 | $2,938,931,000.00 | Buy | 14 | 2012 |
#16 | CSTM | France | $24.71 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#17 | FAF | United States | $65.00 | $7,452,200,000.00 | Strong Buy | 4 | 2009 |
#18 | PAGP | United States | $26.40 | $44,262,000,000.00 | Buy | 10 | 2013 |
#19 | SHAK | United States | $56.61 | $1,445,306,000.00 | Buy | 26 | 2014 |
#20 | DCOM | United States | $40.09 | $19,907,000.00 | Buy | 5 | 1996 |
#21 | PRMB | United States | $19.51 | $6,664,000,000.00 | Buy | 9 | 2025 |
#22 | TRUP | United States | $22.82 | $1,439,305,000.00 | Buy | 5 | 2014 |
#23 | ASB | United States | $29.10 | $1,102,756,000.00 | Buy | 12 | 2014 |
#24 | PTCT | United States | $63.25 | $264,734,000.00 | Buy | 17 | 2006 |
#25 | DAN | United States | $26.93 | $7,500,000,000.00 | Buy | 5 | 2003 |
#26 | SSRM | United States | $34.37 | $1,629,637,000.00 | Buy | 4 | 1997 |
#27 | QTWO | United States | $55.50 | $193,978,000.00 | Buy | 11 | 2014 |
#28 | KNSA | United Kingdom | $74.69 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#29 | PACS | United States | $42.88 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#30 | TPG | United States | $43.65 | $4,670,212,000.00 | Buy | 15 | 2021 |
#31 | BKV | United States | $21.82 | $893,781,000.00 | Strong Buy | 9 | 2022 |
#32 | EVER | United States | $18.48 | $163,349,000.00 | Strong Buy | 5 | 2018 |
#33 | OOMA | United States | $21.75 | $114,490,000.00 | Strong Buy | 4 | 2015 |
#34 | VTR | United States | $87.34 | $5,833,980,000.00 | Buy | 13 | 2005 |
#35 | FRPT | United States | $57.06 | $1,102,015,000.00 | Buy | 17 | 2014 |
#36 | LEVI | United States | $19.67 | $6,282,000,000.00 | Strong Buy | 12 | 2019 |
#37 | BMY | United States | $62.80 | $48,194,000,000.00 | Buy | 15 | 2006 |
#38 | AORT | United States | $22.77 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#39 | ZVRA | United States | $10.96 | $106,470,000.00 | Strong Buy | 5 | 2015 |
#40 | KNTK | United States | $51.01 | $160,617,000.00 | Buy | 12 | 2017 |
#41 | CALX | United States | $33.00 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#42 | BXMT | United States | $12.44 | $0.00 | Buy | 5 | 1998 |
#43 | NTST | United States | $18.17 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#44 | APEI | United States | $41.00 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#45 | SIRI | United States | $25.92 | $5,425,129,000.00 | Buy | 8 | 1996 |
#46 | CPT | United States | $97.66 | $12,967,000.00 | Buy | 17 | 1995 |
#47 | UMH | United States | $15.51 | $261,754,000.00 | Strong Buy | 4 | 1995 |
#48 | UPST | United States | $23.15 | $1,043,857,000.00 | Buy | 16 | 2020 |
#49 | HQY | United States | $88.45 | $229,525,000.00 | Buy | 14 | 2014 |
#50 | BANC | United States | $17.84 | $1,818,792,000.00 | Strong Buy | 9 | 2002 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (September 28, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.